ambrisentan NDC 47335-236

NDC codes

FDA NDC Directory

Product NDC (as listed)47335-236Labeler and product segments. Claims need a package NDC.

Product NDC at billing width47335-0236Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
47335-236-64	47335023664	3 BLISTER PACK in 1 CARTON (47335-236-64) / 10 TABLET, FILM COATED in 1 BLISTER PACK (47335-236-60)Marketed from Apr 29, 2019
47335-236-66	47335023666	1 BLISTER PACK in 1 CARTON (47335-236-66) / 10 TABLET, FILM COATED in 1 BLISTER PACK (47335-236-60)Marketed from Apr 29, 2019
47335-236-83	47335023683	30 TABLET, FILM COATED in 1 BOTTLE (47335-236-83)Marketed from Apr 29, 2019
47335-236-85	47335023685	10 TABLET, FILM COATED in 1 BOTTLE (47335-236-85)Marketed from Apr 29, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): ambrisentan
Generic name (nonproprietary): ambrisentan
Active ingredients: Ambrisentan — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210784
Marketing start: Apr 29, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Endothelin Receptor Antagonists (Mechanism)
Identifiers: Product ID 47335-236_294580cb-5622-4f48-89a8-99000a7a2964SPL ID 294580cb-5622-4f48-89a8-99000a7a2964SPL set ID a4978a54-1799-43d6-85dd-05fa9de0a5d7RxCUI 722116, 722122UNII HW6NV07QEC
Pharmacologic class: Endothelin Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N447335023664 followed by a unit qualifier and the quantity

Package 47335-0236-64. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Ambrisentan is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: • To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%). Ambrisentan is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included trials predominantly in patients with WHO Functional…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210784

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210784
Product	Strength	Form · route	Labeler	Product NDC
ambrisentan	Ambrisentan 10 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	47335-237